As of 12 May 2019, a total of 1705 EVD cases, including 1617 confirmed and 88 probable cases, were reported. A total of 1124 deaths were reported (overall case fatality ratio 66%), including 1036 deaths among confirmed cases. Of the 1705 confirmed and probable cases with known age and sex, 56% (951) were female, and 29% (502) were children aged less than 18 years. The number of healthcare workers affected has risen to 101 (6% of total cases).

Ambassador of Brazil to Beirut dies

Search results
Items: 1 to 20 of 2136
<< FirstLast >>
Select item 31063571

Cardiovascular Benefits of SGLT2 Inhibitors and GLP-1 Receptor Agonists in Type 2 Diabetes.

[No authors listed]

JAMA. 2019 May 7;321(17):1720-1721. doi: 10.1001/jama.2019.2702. No abstract available.


Similar articles
Select item 31060053

Fournier Gangrene Associated With Sodium-Glucose Cotransporter-2 Inhibitors: A Review of Spontaneous Postmarketing Cases.

Bersoff-Matcha SJ, Chamberlain C, Cao C, Kortepeter C, Chong WH.

Ann Intern Med. 2019 May 7. doi: 10.7326/M19-0085. [Epub ahead of print]


Similar articles
Select item 31057401

Canagliflozin Inhibits Human Endothelial Cell Proliferation and Tube Formation.

Behnammanesh G, Durante ZE, Peyton KJ, Martinez-Lemus LA, Brown SM, Bender SB, Durante W.

Front Pharmacol. 2019 Apr 16;10:362. doi: 10.3389/fphar.2019.00362. eCollection 2019.


Free Article

Similar articles
Select item 31050384

Effects of sodium-glucose cotransporter 2 inhibitors on risk of venous thromboembolism in patients with type 2 diabetes: A systematic review and meta-analysis.

Wang A, Yang K, Wang T, Zhang N, Tang H, Feng X.

Diabetes Metab Res Rev. 2019 May 3:e3174. doi: 10.1002/dmrr.3174. [Epub ahead of print]


Similar articles
Select item 31050116

Acute Kidney Injury with sodium-glucose linked cotransporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials.

Gilbert RE, Thorpe KE.

Diabetes Obes Metab. 2019 May 3. doi: 10.1111/dom.13754. [Epub ahead of print]


Similar articles
Select item 31050099

Identification of subgroups of patients with type 2 diabetes with differences in renal function preservation between sglt2 inhibitors and dpp4 inhibitors using a supervised machine learning algorithm (profile study): A Retrospective analysis of a japanese commercial medical database.

Zhou FL, Watada H, Tajima Y, Berthelot M, Kang D, Esnault C, Shuto Y, Maegawa H, Koya D.

Diabetes Obes Metab. 2019 May 3. doi: 10.1111/dom.13753. [Epub ahead of print]


Similar articles
Select item 31041781

How Generalizable Are Cardiovascular Outcome Trials of Sodium-Glucose Co-Transporter-2 Inhibitors? A National Database Study: Study Protocol.

Hinton W, Feher MD, Munro N, de Lusignan S.

Diabetes Ther. 2019 Apr 30. doi: 10.1007/s13300-019-0620-8. [Epub ahead of print]


Similar articles
Select item 31041606

Sodium-Glucose Co-Transporter 2 Inhibitors Compared with Sulfonylureas in Patients with Type 2 Diabetes Inadequately Controlled on Metformin: A Meta-Analysis of Randomized Controlled Trials.

Chen Z, Li G.

Clin Drug Investig. 2019 Apr 30. doi: 10.1007/s40261-019-00781-w. [Epub ahead of print] Review.


Similar articles
Select item 31033127

Sodium-glucose co-transporter 2 inhibition with empagliflozin improves cardiac function in non-diabetic rats with left ventricular dysfunction after myocardial infarction.

Yurista SR, Silljé HHW, Oberdorf-Maass SU, Schouten EM, Pavez Giani MG, Hillebrands JL, van Goor H, van Veldhuisen DJ, de Boer RA, Westenbrink BD.

Eur J Heart Fail. 2019 Apr 29. doi: 10.1002/ejhf.1473. [Epub ahead of print]


Similar articles
Select item 31032431

Combined treatment with DPP-4 inhibitor linagliptin and SGLT2 inhibitor empagliflozin attenuates neointima formation after vascular injury in diabetic mice.

Takahashi H, Nomiyama T, Terawaki Y, Horikawa T, Kawanami T, Hamaguchi Y, Tanaka T, Motonaga R, Fukuda T, Tanabe M, Yanase T.

Biochem Biophys Rep. 2019 Apr 19;18:100640. doi: 10.1016/j.bbrep.2019.100640. eCollection 2019 Jul.


Free PMC Article

Similar articles
Select item 31030051

Study on the interaction of ertugliflozin with human serum albumin in vitro by multispectroscopic methods, molecular docking, and molecular dynamics simulation.

Wang W, Gan N, Sun Q, Wu D, Gan R, Zhang M, Tang P, Li H.

Spectrochim Acta A Mol Biomol Spectrosc. 2019 Apr 18;219:83-90. doi: 10.1016/j.saa.2019.04.047. [Epub ahead of print]


Similar articles
Select item 31027990

Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.

Allison R, Goldstein D, Musso MW.

J Emerg Med. 2019 Apr 23. pii: S0736-4679(19)30137-4. doi: 10.1016/j.jemermed.2019.03.011. [Epub ahead of print]


Similar articles
Select item 31026402

SGLT2 inhibitors for the treatment of diabetes: a patent review (2013-2018).

Pandey J, Tamrakar AK.

Expert Opin Ther Pat. 2019 Apr 26:1-16. doi: 10.1080/13543776.2019.1612879. [Epub ahead of print]


Similar articles
Select item 31026373

The protective effect of sodium-glucose cotransporter 2 inhibitors in patients with rapid renal function decline, stage G3 or G4 chronic kidney disease, and type 2 diabetes.

Miyoshi H, Kameda H, Yamashita K, Nakamura A, Kurihara Y.

J Diabetes Investig. 2019 Apr 26. doi: 10.1111/jdi.13064. [Epub ahead of print]


Free Article

Similar articles
Select item 31026084

Pharmacokinetic and Pharmacodynamic Modeling for Renal Function Dependent Urinary Glucose Excretion Effect of Ipragliflozin, a Selective Sodium Glucose Cotransporter 2 (SGLT2) Inhibitor, Both in Healthy Subjects and Patients with Type 2 Diabetes Mellitus.

Saito M, Kaibara A, Kadokura T, Toyoshima J, Yoshida S, Kazuta K, Ueyama E.

Br J Clin Pharmacol. 2019 Apr 26. doi: 10.1111/bcp.13972. [Epub ahead of print]


Similar articles
Select item 31016172

Fournier’s Gangrene and Sodium-glucose Co-transporter 2(SGLT2) Inhibitors: Our Experience.

Dass AS, Immaculate G, Bhattacharyya A.

Indian J Endocrinol Metab. 2019 Jan-Feb;23(1):165-166. doi: 10.4103/ijem.IJEM_614_18. No abstract available.


Free PMC Article

Similar articles
Select item 31016169

Sodium Glucose Co-transporter-2 Inhibitor: Benefits beyond Glycemic Control.

Baruah MP, Makkar BM, Ghatnatti VB, Mandal K.

Indian J Endocrinol Metab. 2019 Jan-Feb;23(1):140-149. doi: 10.4103/ijem.IJEM_160_17. Review.


Free PMC Article

Similar articles
Select item 31016146

High Prevalence of Genital Mycotic Infections with Sodium-glucose Co-transporter 2 Inhibitors among Indian Patients with Type 2 Diabetes.

Aggarwal A, Wadhwa R, Kapoor D, Khanna R.

Indian J Endocrinol Metab. 2019 Jan-Feb;23(1):9-13. doi: 10.4103/ijem.IJEM_244_18.


Free PMC Article

Similar articles
Select item 31005757

Assessment of the benefit-risk balance of SGLT2 inhibitors: Commentary on a new ‘French paradox’.

Scheen AJ, Darmon P, Hanaire H; writing committee of the position statement by the French-Speaking Society of Diabetes (SFD).

Diabetes Metab. 2019 Apr 18. pii: S1262-3636(19)30061-8. doi: 10.1016/j.diabet.2019.04.001. [Epub ahead of print] No abstract available.


Similar articles
Select item 31004234

Inhibition of sodium-glucose cotransporter-2 preserves cardiac function during regional myocardial ischemia independent of alterations in myocardial substrate utilization.

Baker HE, Kiel AM, Luebbe ST, Simon BR, Earl CC, Regmi A, Roell WC, Mather KJ, Tune JD, Goodwill AG.

Basic Res Cardiol. 2019 Apr 19;114(3):25. doi: 10.1007/s00395-019-0733-2.


Similar articles

Venezuela , a rich oil producer coutnry-  do not manage to  give  drinking water to its   over 30  million people.

Leaders  seem  have much  personal  quarrels, antipaties , iontolerances   and  fights,  and own intresses ,lacking   ability to diplomacy and responsible  ruling over nations´s    multimillion multitudes which  still are   waiting  a Good  Shephard  in this  world time, but they are  only   suffering still  every day more. Even death toll  because of miseries  is going upwards.  The worsest thing is  man made deaths:  violent cruel killings of   civilians.

It is a civil wsar:  most cruel of all wars:   A neighbour killing  neighbours.



Drug trafficking routes

Aircraft activity of drug trafficking suspects tracked by the United States Southern Command showing multiple drug flights from Venezuela in 2010.

According to a 2009 US report, 90% of US cocaine is sourced from Colombia, with Venezuela and the Caribbean accounting for around 10% of US-destined cocaine trans-shipments in 2010.[6] Another significant route is directed to export cocaine, marijuana and other illegal drugs via direct sea shipments from Venezuela to Europe, with half of all direct shipments to Europe between 2006 and 2008 originating in Venezuela.[7][8]

Gustavo Tarre Briceño is a Venezuelan politician, lawyer, author, professor of constitutional law and politic science, and representative to the Organization of American States (OAS).

Tarre was named by Venezuela’s National Assembly as a Special Representative to the OAS on 22 January during the 2019 Venezuelan presidential crisis.[1][2] On 9 April 2019, the OAS voted to accept him as the ambassador and representative from Venezuela.[3]



Ezechiel 1:16

May 3, 2019

In 13 counties  is functionin  the Columbian  active querilla

Tarre Briceño alerta ante la OEA que Hezbolá y el Estado Islámico operan en Venezuela

Many senselessness,  utterly cruel and inhuman  genocidic wars  has  a background in narcotica use.

Afganistan war. opium  and heroin use.

Isis war, islamic ears:: Hash, cannabis, marihuana and  other plant  narcotics.

German nazists.  Amphetamine derivata, pervitiin.

Maduro war: Cocain.

All kind of African  wars. local  narcotic  toxis plants.


Article and   video  has been  robbed  from  internet. you tube video from the Hospital Jose Ignacio Baldo( caracas) . Now abandoned, looted.

El Infierno de los hospitales de Venezuela | Qué Vaina!

Översätt den här sidan
17 apr. 2019 – EL Hospital General Dr. José Ignacio Baldó también conocido como Hospital El … Libertador del Distrito Capital, al oeste de la ciudad de Caracas y al centro … Hace 80 años el hospital José ignacio Baldó (El Algodonal) era …

Leabright's Blog

Just another weblog is the best place for your personal blog or business site.